Abstract: In 2006, Shinya Yamanaka, MD, PhD, discovered that adult somatic cells can be reprogrammed into an embryonic-like pluripotent state by delivering transcription factors. These reprogrammed cells, known as induced pluripotent stem (iPS) cells, have the potential to develop into every cell type in the body and are invaluable tools for disease modeling, drug screening, and cell therapy. iPS cells also provide an unprecedented opportunity for discovery in life science, and in Yamanaka’s lab today, researchers continue to use them to investigate the mechanisms for cell fate determination, the reprogramming process, and pluripotency. Dr. Yamanaka, 2012 winner of the Nobel Peace Prize in Physiology and Medicine, will deliver the keynote address live for the Harvard Annual Bioethics Conference, Biotechnology and the Future of Medicine.
Register here.
Sponsored by the Harvard Medical School Center for Bioethics
Location and Address
Online